Physician profile
Ajay Sethi
NPI 1538745096
$10,605.40
in general payments reported to CMS, 2019-2025
12 companies · $10K in 2025
The $10K reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $127 · 2024: $142 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Food and Beverage: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Food and Beverage | $404.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,000.00 | 2025 | Activa PC |
| Amgen INC. | $120.87 | 2024 | Uplizna |
| Horizon Therapeutics Plc | $101.94 | 2022 | |
| Biogen, INC. | $56.83 | 2025 | Skyclarys |
| Acadia Pharmaceuticals INC | $50.50 | 2025 | Nuplazid |
| Jazz Pharmaceuticals INC. | $46.47 | 2022-2024 | |
| Boston Scientific Corporation | $37.12 | 2025 | General - Therapies |
| Argenx US, INC. | $33.34 | 2025 | Vyvgart Hytrulo |
| Ucb, INC. | $25.19 | 2025 | Zilbrysq |
| Eisai INC. | $24.39 | 2025 | |
| Sk Life Science, INC. | $19.44 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.14 | 2025 | Hyqvia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Sethi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.